Status:
COMPLETED
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Primary Hypertension
Eligibility:
MALE
18-40 years
Phase:
PHASE3
Brief Summary
The Renin-Angiotensin-Aldosterone-system is important in the development of cardiovascular organ damage caused by arterial hypertension. This study aims at evaluating the importance of aldosterone wit...
Eligibility Criteria
Inclusion
- Clinical diagnosis hypertension (BP higher than 139/89)
Exclusion
- Antihypertensive pretreatment
- Contraindications against spironolactone
- Being unable to understand or comply with study procedures
Key Trial Info
Start Date :
March 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00865501
Start Date
March 1 2008
End Date
December 1 2009
Last Update
July 10 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Erlangen-Nürnberg, Nephrology and Hypertension
Erlangen, Germany, 91054